org placeholder image

Amanda Roodhouse

Senior Director, Regulatory Affairs at QED Therapeutics

  • LinkedIn

Email Email: a****@qedtx.com

phone noPhone Number: (***)-***-****

map
QED THERAPEUTICS

QED THERAPEUTICS

  • description Description
    QED Therapeutics, an affiliate company of BridgeBio Pharma, is dedicated to developing meaningful treatment options for those with achondroplasia and pursuing research to address the needs of...

    Read More

  • Employees count Employees 11-50
  • Revenue Revenue 25 Million to 50 Million
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

QED Therapeutics Org Chart and Mapping

Employees

Ariana Salvatici

Associate Medical Director

Harris Soifer

Senior Director, Translational Medicine

Brian Boyles

Associate Director, Quality Assurance

Anne Lee

Senior Director, Global Patient Advocacy

Jacki Fontaine

Senior Director, Clinical Operations

Grace Kim

Clinical Research Associate

Frequently Asked Questions Regarding Amanda Roodhouse

Answer: Amanda Roodhouse works for QED Therapeutics as Senior Director, Regulatory Affairs

Answer: Amanda Roodhouse’s role in QED Therapeutics is Senior Director, Regulatory Affairs

Answer: Amanda Roodhouse's email address is a***@gmail.com

Answer: Amanda Roodhouse's business email address is a****@qedtx.com

Answer: Amanda Roodhouse’s direct phone number is (***)-***-****

Answer: Amanda Roodhouse works in the industry of: Biotechnology

Answer: Amanda Roodhouse works QED Therapeutics located at 421 Kipling St, Palo Alto, California, 94301, United States

Answer: QED Therapeutics's Senior Director, Regulatory Affairs is Amanda Roodhouse

Answer: Amanda Roodhouse contact details:

  • Phone number  :  (***)-***-****
  • Email  :  a****@qedtx.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access